🎉 Congratulations to Dr. Hien Dang, who has been named the J. Wallace Davis and Gail G. Davis Chair in Surgery @JEFFSurgery! 👏

Hien Dang, PhD studies #livercancer , which is the third leading cause of cancer death worldwide, and can be difficult to treat.

Check it out- our very own Dr. abodz shares how he prioritizes his own wellness while being a transplant surgeon, colleague, mentor, husband & father:

“My attending wants to talk to you”

We're proud to announce that the Sidney Kimmel Cancer Center – Jefferson Health (SKCC) has earned a National Cancer Institute (NCI) 'Comprehensive' Cancer Center designation, the highest recognition awarded by the NCI. Read more: brnw.ch/21wIXAS #TeamJefferson

Great news!!! Proud to work alongside amazing colleagues Sidney Kimmel Cancer Center – Jefferson Health Jefferson Health

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive solid tumors. fda.gov/drugs/resource…

#OCENewsBurst

Today we join in celebrating #InternationalWomensDay by recognizing the amazing women of the Sidney Kimmel Cancer Center. Whether they are in the laboratory, the clinic, or out in the community, they are making a difference in our patients' lives and inspire us every day!

Just one week until the Honickman Center's ribbon cutting!

The new home of Jefferson’s nationally ranked specialty programs, the Honickman Center will offer one-stop access to care in a stunning space. Learn more: brnw.ch/21wHCoF

#TrialTuesday : STELLAR-303 is a phase III #clinicaltrial evaluating the novel tyrosine kinase inhibitor XL092 (zanzalintinib) + atezolizumab versus regorafenib in patients with metastatic #colorectalcancer ➡️ jeffersonhealth.org/clinical-speci…
#ColorectalCancerAwarenessMonth Daniel Lin, MD

My mom was one of the reasons I became a doctor and oncologist. She dedicated her life to treating cancer, and taught me to care for patients like they were family. Unfortunately, she was taken from us too soon. Mom, I will miss you dearly. May you find peace and serenity. ❤️🕊️

We are profoundly grateful that Dr. Ruth Gottesman, Professor Emerita of Pediatrics at Albert Einstein College of Medicine - Official, has made a transformational gift to #MontefioreEinstein —the largest to any medical school in the country—that ensures no student has to pay tuition again. bit.ly/3wvBj7y

Seems relevant to resurface Dr Andrew Ko’s observation at #asco23 that orders of magnitude separate the cost of NALIRIFOX vs FOLFIRINOX ‼️

Precision treatment in advanced hepatocellular carcinoma
Cancer Cell
doi.org/10.1016/j.ccel…
👏Excellent review on precision medicine
👉biomarkers, molecular classifications, heterogeneity of TME..
🧐many molecular 💊, but so far no 🎯💊 in HCC
ESMO - Eur. Oncology ILCA EASLnews

LT Results of Organ Preservation in Patients w/ Rectal cancer Treated With TNT
Journal of Clinical Oncology
doi.org/10.1200/JCO.23…
🔎Phs II OPRA
👉50% preserved rectum after 5 yrs
👉CRT-CNCT better than INCT-CRT
👉all regrowth in WW during first 2 yrs
👉Similar outcome w/ salvage TME
ESMO - Eur. Oncology

A true giant in the field of oncology. Edith Mitchell, M.D. broke barriers and was tirelessly devoted to the care of her patients and the pursuit of health equity. She will be missed dearly. 🙏

‼️ Rise in young onset GI cancers! #GI24
➡️ #CRC leading cause of cancer death in men & 2nd in women
➡️many reasons -lots unknown
➡️rise in #PancreaticCancer #livercancer
➡️Pt needs different eg fertility
➡️Profiling imp in all inc PDAC 👇Erica Tsang
👏 fab talk Kimmie Ng, MD, MPH

Early onset GI cancers will be highlighted at ASCO #GI24

EO-EGC is rising along with CRC. Our results in JNCI show EO-EGC is:
⬆️gastric ⬆️diffuse type
🟰 stage/survival
Much still unknown
Fantastic collaboration Andrea Cercek Yelena Y. Janjigian MD Steve Maron Memorial Sloan Kettering Cancer Center

NETTER-2 shows PRRT gives huge PFS benefit over octreotide on first line treatment of Neuroendocrine disease (HR 0.26)

Is this PFS data practice changing for you ?

#GI24

🔎NIVO/IPI vs chemo as 1L treatment for MSI-H/dMMR mCRC
🔎CheckMate 8HW phs 3, 303 pts
👉mPFS: nr vs 5.8 mo, HR: 0.21!
😅just amazing...nothing to add...
ESMO - Eur. Oncology

The middle pie chart worries (and sometimes infuriates) me

1) 'Hemorrhoids' are presumptive unless you perform a rectal exam or scope

2) Iron deficiency anemia in young women is not always from/proportionate to menstrual loss (some of my female CRC pts are amenorrheic!)

#GI24